A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.

Clinical trial NCT06766552 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06766552
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Ankylosing Spondylitis (AS)Psoriatic Arthritis (PsA)Nr-axSpA Polymyalgia Rheumatica (PMR)Takayasu Arteritis (TAK)Giant Cell Arteritis (GCA)Behcet's Disease Enthesitis-related Arthritis

Start date: 2025-01-30
Primary completion: 2029-12-30
Enrollment: 10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.